QSUNT contributes honorably to the global study on the potential of artificial intelligence in radiotherapy treatment of head and neck tumors, "ELAISA," alongside 98 participants from five continents.
The conclusions of this scientific research were published in The European Society for Radiotherapy and Oncology (ESTRO) Journal 2024..
Albania contributed to this study alongside 98 researchers from 23 University Radiotherapy Clinics across 5 continents, with an outstanding team of doctors from QSUNT, led by the head of the Radiotherapy Unit, Orges Spahiu, as the principal scientific investigator, along with the hospital's doctors Bianka Shima, Borjana Jahaj, and Aurora Aliraj.
This rare large-scale study, coordinated by the International Atomic Energy Agency (IAEA), investigated the potential of artificial intelligence (AI) to enhance contouring capabilities in radiotherapy, increasing accuracy in the treatment of head and neck cancer patients and reducing treatment preparation time.
The study's conclusions recognized the high quality of delineation by the participants, while its findings highlighted the extraordinary potential of artificial intelligence in enhancing quality and reducing the preparation time of radiotherapy treatment plans worldwide.
This study was conceived as part of initiatives to reduce the gap in access to cancer care through smart solutions for the efficient use of resources.
The doctors of QSUNT contributed with three other scientific papers in The European Society for Radiotherapy and Oncology (ESTRO) Journal 2024..
Leave feedback about this